ArticleOncotarget2017

Oncogenic driver mutations, treatment, and EGFR-TKI resistance in a Caucasian population with non-small cell lung cancer: survival in clinical practice.

Martin Faehling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.